Showing 341-350 of 2253 results for "".
Understanding Disparities Associated with Alzheimer Disease and Related Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/understanding-disparities-associated-with-alzheimer-disease-and-related-dementias/32142/Clinicians need to take into consideration a variety of factors resulting in disparities in health outcomes in people with dementia, including socioeconomic status, race, ethnicity, environment, life experiences, and culture.Movement Disorders Moment: Parkinson Disease in the COVID-19 Era
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-parkinson-disease-in-the-covid-19-era/31774/The pandemic has risks for people with Parkinson disease both from COVID-19 and effects of the lockdown and raises questions about future risk of parkinsonism.Telemedicine for Pain & Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/telemedicine-for-pain-headache/31790/With creativity and patience, headache and pain can be assessed in a telemedicine visit.Palliative Care Skills for Pediatric Neurology
https://practicalneurology.com/diseases-diagnoses/child-neurology/palliative-care-skills-for-pediatric-neurology/31845/Palliative care aims to improve quality of life, is appropriate at any stage of illness, and can be provided alongside treatment intended to cure.Disparities in Alzheimer Disease and Alzheimer-Related Dementias: Considerations for Clinical Decision-Making and Treatment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disparities-in-alzheimer-disease-and-alzheimer-related-dementias-considerations-for-clinical-decision-making-and-treatment/32016/Taking into account social determinants of health and identifying solutions to improve patient care.Headache Medicine Update: What’s New in CGRP Functional Blocking Agents
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-medicine-update-whats-new-in-cgrp-functional-blocking-agents/32126/CGRP blocking agents have demonstrated success in migraine treatment and can be used in various settings, in different combinations, and for different headache conditions.Cannabinoids and Psychedelics for Headache Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-psychedelics-for-headache-management/32131/Reports of success in self-treatment of primary headache disorders with cannabis and psilocybin have led to clinical trials studying their efficacy and safety.Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.Neuromuscular Notes: A Practical Approach to the Diagnosis and Management of Muscle Cramps
https://practicalneurology.com/diseases-diagnoses/neuromuscular/a-practical-approach-to-the-diagnosis-and-management-of-muscle-cramps/36116/Frequent or severe muscle cramps can cause prolonged postcramp soreness and diminish quality of life by disrupting sleep, limiting physical activity, and provoking anxiety about symptom recurrence.A Practical Approach to Selecting Patients for Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-practical-approach-to-selecting-patients-for-amyloid-targeting-treatments/36190/A review of the clinical criteria, key challenges, and future directions in selecting patients for amyloid-targeting treatments.